Market Tracker

08/22 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

0.86
Delayed Data
As of 4:00pm ET
 +0.0136 / +1.61%
Today’s Change
0.79
Today|||52-Week Range
3.65
-61.78%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.85
Today’s open0.85
Day’s range0.81 - 0.88
Volume600,757
Average volume (3 months)832,115
Market cap$87.8M
Dividend yield--
Data as of 4:00pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+36.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book0.80

Competitors

 Today’s
change
Today’s
% change
CRMECardiome Pharma Corp-0.49-18.85%
LPCNLipocine Inc-0.02-0.48%
AFMDAffimed NV0.000.00%
GTXIGTX Inc+0.15+2.66%
Data as of 4:00pm ET, 08/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts